News Choose Year All Years 2025 (4) 2024 (6) 2023 (2) 2022 (2) 2021 (1) Search Press Releases Found 15 Results May 21, 2025 Rectify Pharma to Present Translational Data on Novel Approach to Treat Chronic Kidney Disease and Vascular Calcification at ERA 2025 Read More May 9, 2025 Rectify Pharma Presents Translational Data for Novel Positive Functional Modulator Demonstrating Improved Biliary and Liver Health at EASL 2025 Read More April 23, 2025 Rectify Pharma to Share Preclinical Data Highlighting Progress in Hepatobiliary Program at EASL 2025 Read More April 7, 2025 Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology Read More November 18, 2024 Rectify Pharma Presents Preclinical Data Supporting Development of Lead Candidate RTY-694 at The Liver Meeting® 2024 Read More November 12, 2024 Rectify Pharma to Host Virtual R&D Event on RTY-694 for Primary Sclerosing Cholangitis and Other Hepatobiliary Diseases on November 21, 2024 Read More October 22, 2024 Rectify Pharma Announces Positive Functional Modulator RTY-694 as Development Candidate for Primary Sclerosing Cholangitis Read More October 17, 2024 Rectify Pharmaceuticals to Present New Preclinical Data at The American Association for the Study of Liver Diseases Annual Meeting Read More 12»
Read More